Ever wondered if Quest Diagnostics stock is actually a bargain right now, or just riding the latest market waves? You are in the right place to get some clarity. The stock has made an impressive move, ...
It’s relatively common for a hospital or physician’s office to hire a diagnostics company to manage its in-house laboratory.
In the fast-growing diagnostics testing market, Hologic HOLX and Quest Diagnostics DGX stand out as two prominent players, ...
According to Benzinga Pro, Quest Diagnostics Inc's peer group average for short interest as a percentage of float is 9.92%, which means the company has less short interest than most of its peers. Did ...
Octave is collaborating with Quest Diagnostics to expand access to its MSDA blood test, used to measure disease activity in ...
Although this is one route for a diagnostic device, securing FDA approval allows Cleveland Diagnostics to send IsoPSA kits ...
Two California residents are pressing to revive their claim that Quest violated California's wiretap law by allegedly sharing website visitors' browsing data with Meta.
Octave Bioscience, a commercial-stage precision care company pioneering a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases such as Parkinson's disease, today ...
Octave Bioscience, a commercial-stage precision care company pioneering a new standard for managing multiple sclerosis (MS) ...
"The whole future of precision medicine for MS and Parkinson's is managing to the biology of the disease to individualize the ...
Hims & Hers Health stock has seen its fair value estimate trimmed from about $46.00 to roughly $44.36 per share, even as analysts grow more optimistic about its long term revenue trajectory. Stronger ...
Quest Diagnostics, a cancer treatment laboratory in Lewisville, received a proclamation from Lewisville City Council after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback